In CEO Jensen Huang's brave new world, AI is part of people's daily activities and Nvidia plays a key role.

ROYERSFORD, Pa., May 29, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest community, Canterbury Meadows , is coming soon to Royersford, Pennsylvania. This exclusive Toll Brothers neighborhood will include a selection of modern two-story home designs and an array of luxury amenities. Site work is underway at 183 Kline Road in Royersford, and the community is anticipated to open for sale in fall 2025.

Investors with an interest in Consumer Products - Staples stocks have likely encountered both Grocery Outlet Holding Corp. (GO) and Colgate-Palmolive (CL). But which of these two stocks is more attractive to value investors?

Investors interested in stocks from the Internet - Software sector have probably already heard of Bumble Inc. (BMBL) and F5 Networks (FFIV). But which of these two stocks offers value investors a better bang for their buck right now?

Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Pfizer (PFE) or Eli Lilly (LLY). But which of these two stocks presents investors with the better value opportunity right now?

Investors looking for stocks in the Waste Removal Services sector might want to consider either H20 (HTO) or Casella (CWST). But which of these two stocks presents investors with the better value opportunity right now?

Investors looking for stocks in the Utility - Electric Power sector might want to consider either Evergy Inc (EVRG) or OGE Energy (OGE). But which of these two companies is the best option for those looking for undervalued stocks?

SOFI and NU face off as fintech disruptors. See how their growth, profits and digital models stack up in this in-depth head-to-head analysis.

AVO and CVGW battle for avocado supremacy with global sourcing, innovative strategies and expanding portfolios driving growth in the fresh produce market.

Bristol Myers' Opdivo SC wins EU approval as the first PD-1 inhibitor for subcutaneous use across multiple solid tumor indications.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Toro (TTC) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does HNI (HNI) have what it takes?

C3.ai (NYSE:AI) shares surged more than 26% after the enterprise AI software firm's fiscal fourth quarter earnings topped analyst expectations for revenue and profit, driven by accelerating demand for its Generative AI products and an uptick in partner-driven deals. Revenue for Q4 rose 26% year-over-year to $108.7 million, beating estimates of $107.8 million, while net loss per share of $0.16 came in ahead of the expected $0.20 loss.

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=150751&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq.

U.S. crude oil inventories fell by 2.8 million barrels, exceeding estimates for a drop of 600,000 barrels.

CHICAGO--(BUSINESS WIRE)--ComEd today announced that the Illinois Commerce Commission (ICC) has approved its second Beneficial Electrification (BE) Plan, investing approximately $168 million over a three-year period beginning in 2026. The continuation of ComEd's BE funding marks a significant step forward in ComEd's commitment to advancing electric vehicle (EV) adoption and reducing emissions in northern Illinois. Building on its current $231 million investment in beneficial electrification, de.

Salt Lake City, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company, today announced the authorization of a stock repurchase program of up to $2 million of TruGolf's Class A common stock.

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. ("NeuroPace" or "the Company") (NASDAQ:NPCE). Investors who purchased NeuroPace securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NPCE.

The U.S. Food and Drug Administration (FDA) approved Eton Pharmaceuticals, Inc.'s ETON new drug application (NDA) for Khindivi (hydrocortisone) oral solution as a replacement therapy for pediatric patients five years of age and older with adrenocortical insufficiency.

SRE is expected to gain from planned investments and LNG projects. Yet, valuation concerns and wildfire events may impact its operations.